[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Oral Contraceptive Drugs Market Insights, Forecast to 2029

November 2023 | 113 pages | ID: G3CAAD237751EN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents an overview of global market for Oral Contraceptive Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Oral Contraceptive Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Oral Contraceptive Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Contraceptive Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Oral Contraceptive Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Oral Contraceptive Drugs sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Bayer, Pfizer, Teva Pharmaceutical, Merck, Actavis, Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S and ZiZhu, etc.

By Company
  • Bayer
  • Pfizer
  • Teva Pharmaceutical
  • Merck
  • Actavis
  • Johnson & Johnson
  • Gedeon Richter
  • Novo Nordisk A/S
  • ZiZhu
  • Baijingyu
  • Huazhong
Segment by Type
  • Long-acting Contraceptives
  • Short-acting Contraceptives
  • Emergency Contraceptives
Segment by Application
  • Hospital
  • Pharmacy
  • Other
Segment by Region
  • US & Canada
    • U.S.
    • Canada
  • China
  • Asia (excluding China)
    • Japan
    • South Korea
    • China Taiwan
  • Southeast Asia
    • India
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Middle East, Africa, Latin America
    • Brazil
    • Mexico
    • Turkey
    • Israel
    • GCC Countries
Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Oral Contraceptive Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Oral Contraceptive Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.

Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 8: China by type, by application sales and revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Contraceptive Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.
1 STUDY COVERAGE

1.1 Oral Contraceptive Drugs Product Introduction
1.2 Market by Type
  1.2.1 Global Oral Contraceptive Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  1.2.2 Long-acting Contraceptives
  1.2.3 Short-acting Contraceptives
  1.2.4 Emergency Contraceptives
1.3 Market by Application
  1.3.1 Global Oral Contraceptive Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  1.3.2 Hospital
  1.3.3 Pharmacy
  1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global Oral Contraceptive Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Oral Contraceptive Drugs Revenue by Region
  2.2.1 Global Oral Contraceptive Drugs Revenue by Region: 2018 VS 2022 VS 2029
  2.2.2 Global Oral Contraceptive Drugs Revenue by Region (2018-2023)
  2.2.3 Global Oral Contraceptive Drugs Revenue by Region (2024-2029)
  2.2.4 Global Oral Contraceptive Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Oral Contraceptive Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Oral Contraceptive Drugs Sales by Region
  2.4.1 Global Oral Contraceptive Drugs Sales by Region: 2018 VS 2022 VS 2029
  2.4.2 Global Oral Contraceptive Drugs Sales by Region (2018-2023)
  2.4.3 Global Oral Contraceptive Drugs Sales by Region (2024-2029)
  2.4.4 Global Oral Contraceptive Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America

3 COMPETITION BY MANUFACTURES

3.1 Global Oral Contraceptive Drugs Sales by Manufacturers
  3.1.1 Global Oral Contraceptive Drugs Sales by Manufacturers (2018-2023)
  3.1.2 Global Oral Contraceptive Drugs Sales Market Share by Manufacturers (2018-2023)
  3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Contraceptive Drugs in 2022
3.2 Global Oral Contraceptive Drugs Revenue by Manufacturers
  3.2.1 Global Oral Contraceptive Drugs Revenue by Manufacturers (2018-2023)
  3.2.2 Global Oral Contraceptive Drugs Revenue Market Share by Manufacturers (2018-2023)
  3.2.3 Global Top 10 and Top 5 Companies by Oral Contraceptive Drugs Revenue in 2022
3.3 Global Key Players of Oral Contraceptive Drugs, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Oral Contraceptive Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
  3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  3.5.2 Global Oral Contraceptive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Oral Contraceptive Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Oral Contraceptive Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Oral Contraceptive Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

4.1 Global Oral Contraceptive Drugs Sales by Type
  4.1.1 Global Oral Contraceptive Drugs Historical Sales by Type (2018-2023)
  4.1.2 Global Oral Contraceptive Drugs Forecasted Sales by Type (2024-2029)
  4.1.3 Global Oral Contraceptive Drugs Sales Market Share by Type (2018-2029)
4.2 Global Oral Contraceptive Drugs Revenue by Type
  4.2.1 Global Oral Contraceptive Drugs Historical Revenue by Type (2018-2023)
  4.2.2 Global Oral Contraceptive Drugs Forecasted Revenue by Type (2024-2029)
  4.2.3 Global Oral Contraceptive Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Oral Contraceptive Drugs Price by Type
  4.3.1 Global Oral Contraceptive Drugs Price by Type (2018-2023)
  4.3.2 Global Oral Contraceptive Drugs Price Forecast by Type (2024-2029)

5 MARKET SIZE BY APPLICATION

5.1 Global Oral Contraceptive Drugs Sales by Application
  5.1.1 Global Oral Contraceptive Drugs Historical Sales by Application (2018-2023)
  5.1.2 Global Oral Contraceptive Drugs Forecasted Sales by Application (2024-2029)
  5.1.3 Global Oral Contraceptive Drugs Sales Market Share by Application (2018-2029)
5.2 Global Oral Contraceptive Drugs Revenue by Application
  5.2.1 Global Oral Contraceptive Drugs Historical Revenue by Application (2018-2023)
  5.2.2 Global Oral Contraceptive Drugs Forecasted Revenue by Application (2024-2029)
  5.2.3 Global Oral Contraceptive Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Oral Contraceptive Drugs Price by Application
  5.3.1 Global Oral Contraceptive Drugs Price by Application (2018-2023)
  5.3.2 Global Oral Contraceptive Drugs Price Forecast by Application (2024-2029)

6 US & CANADA

6.1 US & Canada Oral Contraceptive Drugs Market Size by Type
  6.1.1 US & Canada Oral Contraceptive Drugs Sales by Type (2018-2029)
  6.1.2 US & Canada Oral Contraceptive Drugs Revenue by Type (2018-2029)
6.2 US & Canada Oral Contraceptive Drugs Market Size by Application
  6.2.1 US & Canada Oral Contraceptive Drugs Sales by Application (2018-2029)
  6.2.2 US & Canada Oral Contraceptive Drugs Revenue by Application (2018-2029)
6.3 US & Canada Oral Contraceptive Drugs Market Size by Country
  6.3.1 US & Canada Oral Contraceptive Drugs Revenue by Country: 2018 VS 2022 VS 2029
  6.3.2 US & Canada Oral Contraceptive Drugs Sales by Country (2018-2029)
  6.3.3 US & Canada Oral Contraceptive Drugs Revenue by Country (2018-2029)
  6.3.4 US
  6.3.5 Canada

7 EUROPE

7.1 Europe Oral Contraceptive Drugs Market Size by Type
  7.1.1 Europe Oral Contraceptive Drugs Sales by Type (2018-2029)
  7.1.2 Europe Oral Contraceptive Drugs Revenue by Type (2018-2029)
7.2 Europe Oral Contraceptive Drugs Market Size by Application
  7.2.1 Europe Oral Contraceptive Drugs Sales by Application (2018-2029)
  7.2.2 Europe Oral Contraceptive Drugs Revenue by Application (2018-2029)
7.3 Europe Oral Contraceptive Drugs Market Size by Country
  7.3.1 Europe Oral Contraceptive Drugs Revenue by Country: 2018 VS 2022 VS 2029
  7.3.2 Europe Oral Contraceptive Drugs Sales by Country (2018-2029)
  7.3.3 Europe Oral Contraceptive Drugs Revenue by Country (2018-2029)
  7.3.4 Germany
  7.3.5 France
  7.3.6 U.K.
  7.3.7 Italy
  7.3.8 Russia

8 CHINA

8.1 China Oral Contraceptive Drugs Market Size
  8.1.1 China Oral Contraceptive Drugs Sales (2018-2029)
  8.1.2 China Oral Contraceptive Drugs Revenue (2018-2029)
8.2 China Oral Contraceptive Drugs Market Size by Application
  8.2.1 China Oral Contraceptive Drugs Sales by Application (2018-2029)
  8.2.2 China Oral Contraceptive Drugs Revenue by Application (2018-2029)

9 ASIA (EXCLUDING CHINA)

9.1 Asia Oral Contraceptive Drugs Market Size by Type
  9.1.1 Asia Oral Contraceptive Drugs Sales by Type (2018-2029)
  9.1.2 Asia Oral Contraceptive Drugs Revenue by Type (2018-2029)
9.2 Asia Oral Contraceptive Drugs Market Size by Application
  9.2.1 Asia Oral Contraceptive Drugs Sales by Application (2018-2029)
  9.2.2 Asia Oral Contraceptive Drugs Revenue by Application (2018-2029)
9.3 Asia Oral Contraceptive Drugs Sales by Region
  9.3.1 Asia Oral Contraceptive Drugs Revenue by Region: 2018 VS 2022 VS 2029
  9.3.2 Asia Oral Contraceptive Drugs Revenue by Region (2018-2029)
  9.3.3 Asia Oral Contraceptive Drugs Sales by Region (2018-2029)
  9.3.4 Japan
  9.3.5 South Korea
  9.3.6 China Taiwan
  9.3.7 Southeast Asia
  9.3.8 India

10 MIDDLE EAST, AFRICA AND LATIN AMERICA

10.1 Middle East, Africa and Latin America Oral Contraceptive Drugs Market Size by Type
  10.1.1 Middle East, Africa and Latin America Oral Contraceptive Drugs Sales by Type (2018-2029)
  10.1.2 Middle East, Africa and Latin America Oral Contraceptive Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Oral Contraceptive Drugs Market Size by Application
  10.2.1 Middle East, Africa and Latin America Oral Contraceptive Drugs Sales by Application (2018-2029)
  10.2.2 Middle East, Africa and Latin America Oral Contraceptive Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Oral Contraceptive Drugs Sales by Country
  10.3.1 Middle East, Africa and Latin America Oral Contraceptive Drugs Revenue by Country: 2018 VS 2022 VS 2029
  10.3.2 Middle East, Africa and Latin America Oral Contraceptive Drugs Revenue by Country (2018-2029)
  10.3.3 Middle East, Africa and Latin America Oral Contraceptive Drugs Sales by Country (2018-2029)
  10.3.4 Brazil
  10.3.5 Mexico
  10.3.6 Turkey
  10.3.7 Israel
  10.3.8 GCC Countries

11 COMPANY PROFILES

11.1 Bayer
  11.1.1 Bayer Company Information
  11.1.2 Bayer Overview
  11.1.3 Bayer Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.1.4 Bayer Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.1.5 Bayer Recent Developments
11.2 Pfizer
  11.2.1 Pfizer Company Information
  11.2.2 Pfizer Overview
  11.2.3 Pfizer Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.2.4 Pfizer Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.2.5 Pfizer Recent Developments
11.3 Teva Pharmaceutical
  11.3.1 Teva Pharmaceutical Company Information
  11.3.2 Teva Pharmaceutical Overview
  11.3.3 Teva Pharmaceutical Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.3.4 Teva Pharmaceutical Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.3.5 Teva Pharmaceutical Recent Developments
11.4 Merck
  11.4.1 Merck Company Information
  11.4.2 Merck Overview
  11.4.3 Merck Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.4.4 Merck Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.4.5 Merck Recent Developments
11.5 Actavis
  11.5.1 Actavis Company Information
  11.5.2 Actavis Overview
  11.5.3 Actavis Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.5.4 Actavis Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.5.5 Actavis Recent Developments
11.6 Johnson & Johnson
  11.6.1 Johnson & Johnson Company Information
  11.6.2 Johnson & Johnson Overview
  11.6.3 Johnson & Johnson Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.6.4 Johnson & Johnson Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.6.5 Johnson & Johnson Recent Developments
11.7 Gedeon Richter
  11.7.1 Gedeon Richter Company Information
  11.7.2 Gedeon Richter Overview
  11.7.3 Gedeon Richter Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.7.4 Gedeon Richter Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.7.5 Gedeon Richter Recent Developments
11.8 Novo Nordisk A/S
  11.8.1 Novo Nordisk A/S Company Information
  11.8.2 Novo Nordisk A/S Overview
  11.8.3 Novo Nordisk A/S Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.8.4 Novo Nordisk A/S Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.8.5 Novo Nordisk A/S Recent Developments
11.9 ZiZhu
  11.9.1 ZiZhu Company Information
  11.9.2 ZiZhu Overview
  11.9.3 ZiZhu Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.9.4 ZiZhu Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.9.5 ZiZhu Recent Developments
11.10 Baijingyu
  11.10.1 Baijingyu Company Information
  11.10.2 Baijingyu Overview
  11.10.3 Baijingyu Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.10.4 Baijingyu Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.10.5 Baijingyu Recent Developments
11.11 Huazhong
  11.11.1 Huazhong Company Information
  11.11.2 Huazhong Overview
  11.11.3 Huazhong Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
  11.11.4 Huazhong Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  11.11.5 Huazhong Recent Developments

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

12.1 Oral Contraceptive Drugs Industry Chain Analysis
12.2 Oral Contraceptive Drugs Key Raw Materials
  12.2.1 Key Raw Materials
  12.2.2 Raw Materials Key Suppliers
12.3 Oral Contraceptive Drugs Production Mode & Process
12.4 Oral Contraceptive Drugs Sales and Marketing
  12.4.1 Oral Contraceptive Drugs Sales Channels
  12.4.2 Oral Contraceptive Drugs Distributors
12.5 Oral Contraceptive Drugs Customers

13 MARKET DYNAMICS

13.1 Oral Contraceptive Drugs Industry Trends
13.2 Oral Contraceptive Drugs Market Drivers
13.3 Oral Contraceptive Drugs Market Challenges
13.4 Oral Contraceptive Drugs Market Restraints

14 KEY FINDINGS IN THE GLOBAL ORAL CONTRACEPTIVE DRUGS STUDY


15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

LIST OF TABLES

Table 1. Global Oral Contraceptive Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Long-acting Contraceptives
Table 3. Major Manufacturers of Short-acting Contraceptives
Table 4. Major Manufacturers of Emergency Contraceptives
Table 5. Global Oral Contraceptive Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Oral Contraceptive Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Oral Contraceptive Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Oral Contraceptive Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Oral Contraceptive Drugs Revenue Market Share by Region (2018-2023)
Table 10. Global Oral Contraceptive Drugs Revenue Market Share by Region (2024-2029)
Table 11. Global Oral Contraceptive Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Oral Contraceptive Drugs Sales by Region (2018-2023) & (K MT)
Table 13. Global Oral Contraceptive Drugs Sales by Region (2024-2029) & (K MT)
Table 14. Global Oral Contraceptive Drugs Sales Market Share by Region (2018-2023)
Table 15. Global Oral Contraceptive Drugs Sales Market Share by Region (2024-2029)
Table 16. Global Oral Contraceptive Drugs Sales by Manufacturers (2018-2023) & (K MT)
Table 17. Global Oral Contraceptive Drugs Sales Share by Manufacturers (2018-2023)
Table 18. Global Oral Contraceptive Drugs Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Oral Contraceptive Drugs Revenue Share by Manufacturers (2018-2023)
Table 20. Global Key Players of Oral Contraceptive Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 21. Oral Contraceptive Drugs Price by Manufacturers 2018-2023 (K MT)
Table 22. Global Oral Contraceptive Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Oral Contraceptive Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Contraceptive Drugs as of 2022)
Table 24. Global Key Manufacturers of Oral Contraceptive Drugs, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Oral Contraceptive Drugs, Product Offered and Application
Table 26. Global Key Manufacturers of Oral Contraceptive Drugs, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Oral Contraceptive Drugs Sales by Type (2018-2023) & (K MT)
Table 29. Global Oral Contraceptive Drugs Sales by Type (2024-2029) & (K MT)
Table 30. Global Oral Contraceptive Drugs Sales Share by Type (2018-2023)
Table 31. Global Oral Contraceptive Drugs Sales Share by Type (2024-2029)
Table 32. Global Oral Contraceptive Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Oral Contraceptive Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Oral Contraceptive Drugs Revenue Share by Type (2018-2023)
Table 35. Global Oral Contraceptive Drugs Revenue Share by Type (2024-2029)
Table 36. Oral Contraceptive Drugs Price by Type (2018-2023) & (K MT)
Table 37. Global Oral Contraceptive Drugs Price Forecast by Type (2024-2029) & (K MT)
Table 38. Global Oral Contraceptive Drugs Sales by Application (2018-2023) & (K MT)
Table 39. Global Oral Contraceptive Drugs Sales by Application (2024-2029) & (K MT)
Table 40. Global Oral Contraceptive Drugs Sales Share by Application (2018-2023)
Table 41. Global Oral Contraceptive Drugs Sales Share by Application (2024-2029)
Table 42. Global Oral Contraceptive Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Oral Contraceptive Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Oral Contraceptive Drugs Revenue Share by Application (2018-2023)
Table 45. Global Oral Contraceptive Drugs Revenue Share by Application (2024-2029)
Table 46. Oral Contraceptive Drugs Price by Application (2018-2023) & (K MT)
Table 47. Global Oral Contraceptive Drugs Price Forecast by Application (2024-2029) & (K MT)
Table 48. US & Canada Oral Contraceptive Drugs Sales by Type (2018-2023) & (K MT)
Table 49. US & Canada Oral Contraceptive Drugs Sales by Type (2024-2029) & (K MT)
Table 50. US & Canada Oral Contraceptive Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 51. US & Canada Oral Contraceptive Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Oral Contraceptive Drugs Sales by Application (2018-2023) & (K MT)
Table 53. US & Canada Oral Contraceptive Drugs Sales by Application (2024-2029) & (K MT)
Table 54. US & Canada Oral Contraceptive Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 55. US & Canada Oral Contraceptive Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Oral Contraceptive Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Oral Contraceptive Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 58. US & Canada Oral Contraceptive Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Oral Contraceptive Drugs Sales by Country (2018-2023) & (K MT)
Table 60. US & Canada Oral Contraceptive Drugs Sales by Country (2024-2029) & (K MT)
Table 61. Europe Oral Contraceptive Drugs Sales by Type (2018-2023) & (K MT)
Table 62. Europe Oral Contraceptive Drugs Sales by Type (2024-2029) & (K MT)
Table 63. Europe Oral Contraceptive Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 64. Europe Oral Contraceptive Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Oral Contraceptive Drugs Sales by Application (2018-2023) & (K MT)
Table 66. Europe Oral Contraceptive Drugs Sales by Application (2024-2029) & (K MT)
Table 67. Europe Oral Contraceptive Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 68. Europe Oral Contraceptive Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Oral Contraceptive Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Oral Contraceptive Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 71. Europe Oral Contraceptive Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Oral Contraceptive Drugs Sales by Country (2018-2023) & (K MT)
Table 73. Europe Oral Contraceptive Drugs Sales by Country (2024-2029) & (K MT)
Table 74. China Oral Contraceptive Drugs Sales by Type (2018-2023) & (K MT)
Table 75. China Oral Contraceptive Drugs Sales by Type (2024-2029) & (K MT)
Table 76. China Oral Contraceptive Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 77. China Oral Contraceptive Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Oral Contraceptive Drugs Sales by Application (2018-2023) & (K MT)
Table 79. China Oral Contraceptive Drugs Sales by Application (2024-2029) & (K MT)
Table 80. China Oral Contraceptive Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 81. China Oral Contraceptive Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Oral Contraceptive Drugs Sales by Type (2018-2023) & (K MT)
Table 83. Asia Oral Contraceptive Drugs Sales by Type (2024-2029) & (K MT)
Table 84. Asia Oral Contraceptive Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 85. Asia Oral Contraceptive Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Oral Contraceptive Drugs Sales by Application (2018-2023) & (K MT)
Table 87. Asia Oral Contraceptive Drugs Sales by Application (2024-2029) & (K MT)
Table 88. Asia Oral Contraceptive Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 89. Asia Oral Contraceptive Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Oral Contraceptive Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Oral Contraceptive Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 92. Asia Oral Contraceptive Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Oral Contraceptive Drugs Sales by Region (2018-2023) & (K MT)
Table 94. Asia Oral Contraceptive Drugs Sales by Region (2024-2029) & (K MT)
Table 95. Middle East, Africa and Latin America Oral Contraceptive Drugs Sales by Type (2018-2023) & (K MT)
Table 96. Middle East, Africa and Latin America Oral Contraceptive Drugs Sales by Type (2024-2029) & (K MT)
Table 97. Middle East, Africa and Latin America Oral Contraceptive Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 98. Middle East, Africa and Latin America Oral Contraceptive Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Oral Contraceptive Drugs Sales by Application (2018-2023) & (K MT)
Table 100. Middle East, Africa and Latin America Oral Contraceptive Drugs Sales by Application (2024-2029) & (K MT)
Table 101. Middle East, Africa and Latin America Oral Contraceptive Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Oral Contraceptive Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Oral Contraceptive Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Oral Contraceptive Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Oral Contraceptive Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Oral Contraceptive Drugs Sales by Country (2018-2023) & (K MT)
Table 107. Middle East, Africa and Latin America Oral Contraceptive Drugs Sales by Country (2024-2029) & (K MT)
Table 108. Bayer Company Information
Table 109. Bayer Description and Major Businesses
Table 110. Bayer Oral Contraceptive Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 111. Bayer Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Bayer Recent Developments
Table 113. Pfizer Company Information
Table 114. Pfizer Description and Major Businesses
Table 115. Pfizer Oral Contraceptive Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 116. Pfizer Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Pfizer Recent Developments
Table 118. Teva Pharmaceutical Company Information
Table 119. Teva Pharmaceutical Description and Major Businesses
Table 120. Teva Pharmaceutical Oral Contraceptive Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 121. Teva Pharmaceutical Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Teva Pharmaceutical Recent Developments
Table 123. Merck Company Information
Table 124. Merck Description and Major Businesses
Table 125. Merck Oral Contraceptive Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 126. Merck Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Merck Recent Developments
Table 128. Actavis Company Information
Table 129. Actavis Description and Major Businesses
Table 130. Actavis Oral Contraceptive Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 131. Actavis Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Actavis Recent Developments
Table 133. Johnson & Johnson Company Information
Table 134. Johnson & Johnson Description and Major Businesses
Table 135. Johnson & Johnson Oral Contraceptive Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 136. Johnson & Johnson Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Johnson & Johnson Recent Developments
Table 138. Gedeon Richter Company Information
Table 139. Gedeon Richter Description and Major Businesses
Table 140. Gedeon Richter Oral Contraceptive Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 141. Gedeon Richter Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Gedeon Richter Recent Developments
Table 143. Novo Nordisk A/S Company Information
Table 144. Novo Nordisk A/S Description and Major Businesses
Table 145. Novo Nordisk A/S Oral Contraceptive Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 146. Novo Nordisk A/S Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Novo Nordisk A/S Recent Developments
Table 148. ZiZhu Company Information
Table 149. ZiZhu Description and Major Businesses
Table 150. ZiZhu Oral Contraceptive Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 151. ZiZhu Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. ZiZhu Recent Developments
Table 153. Baijingyu Company Information
Table 154. Baijingyu Description and Major Businesses
Table 155. Baijingyu Oral Contraceptive Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 156. Baijingyu Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Baijingyu Recent Developments
Table 158. Huazhong Company Information
Table 159. Huazhong Description and Major Businesses
Table 160. Huazhong Oral Contraceptive Drugs Sales (K MT), Revenue (US$ Million), Price (K MT) and Gross Margin (2018-2023)
Table 161. Huazhong Oral Contraceptive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Huazhong Recent Developments
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Oral Contraceptive Drugs Distributors List
Table 166. Oral Contraceptive Drugs Customers List
Table 167. Oral Contraceptive Drugs Market Trends
Table 168. Oral Contraceptive Drugs Market Drivers
Table 169. Oral Contraceptive Drugs Market Challenges
Table 170. Oral Contraceptive Drugs Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Oral Contraceptive Drugs Product Picture
Figure 2. Global Oral Contraceptive Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Oral Contraceptive Drugs Market Share by Type in 2022 & 2029
Figure 4. Long-acting Contraceptives Product Picture
Figure 5. Short-acting Contraceptives Product Picture
Figure 6. Emergency Contraceptives Product Picture
Figure 7. Global Oral Contraceptive Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Oral Contraceptive Drugs Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Pharmacy
Figure 11. Other
Figure 12. Oral Contraceptive Drugs Report Years Considered
Figure 13. Global Oral Contraceptive Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Oral Contraceptive Drugs Revenue 2018-2029 (US$ Million)
Figure 15. Global Oral Contraceptive Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Oral Contraceptive Drugs Revenue Market Share by Region (2018-2029)
Figure 17. Global Oral Contraceptive Drugs Sales 2018-2029 ((K MT)
Figure 18. Global Oral Contraceptive Drugs Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Oral Contraceptive Drugs Sales YoY (2018-2029) & (K MT)
Figure 20. US & Canada Oral Contraceptive Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Oral Contraceptive Drugs Sales YoY (2018-2029) & (K MT)
Figure 22. Europe Oral Contraceptive Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Oral Contraceptive Drugs Sales YoY (2018-2029) & (K MT)
Figure 24. China Oral Contraceptive Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Oral Contraceptive Drugs Sales YoY (2018-2029) & (K MT)
Figure 26. Asia (excluding China) Oral Contraceptive Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Oral Contraceptive Drugs Sales YoY (2018-2029) & (K MT)
Figure 28. Middle East, Africa and Latin America Oral Contraceptive Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Oral Contraceptive Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Oral Contraceptive Drugs in the World: Market Share by Oral Contraceptive Drugs Revenue in 2022
Figure 31. Global Oral Contraceptive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Oral Contraceptive Drugs Sales Market Share by Type (2018-2029)
Figure 33. Global Oral Contraceptive Drugs Revenue Market Share by Type (2018-2029)
Figure 34. Global Oral Contraceptive Drugs Sales Market Share by Application (2018-2029)
Figure 35. Global Oral Contraceptive Drugs Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Oral Contraceptive Drugs Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Oral Contraceptive Drugs Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Oral Contraceptive Drugs Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Oral Contraceptive Drugs Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Oral Contraceptive Drugs Revenue Share by Country (2018-2029)
Figure 41. US & Canada Oral Contraceptive Drugs Sales Share by Country (2018-2029)
Figure 42. U.S. Oral Contraceptive Drugs Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Oral Contraceptive Drugs Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Oral Contraceptive Drugs Sales Market Share by Type (2018-2029)
Figure 45. Europe Oral Contraceptive Drugs Revenue Market Share by Type (2018-2029)
Figure 46. Europe Oral Contraceptive Drugs Sales Market Share by Application (2018-2029)
Figure 47. Europe Oral Contraceptive Drugs Revenue Market Share by Application (2018-2029)
Figure 48. Europe Oral Contraceptive Drugs Revenue Share by Country (2018-2029)
Figure 49. Europe Oral Contraceptive Drugs Sales Share by Country (2018-2029)
Figure 50. Germany Oral Contraceptive Drugs Revenue (2018-2029) & (US$ Million)
Figure 51. France Oral Contraceptive Drugs Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Oral Contraceptive Drugs Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Oral Contraceptive Drugs Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Oral Contraceptive Drugs Revenue (2018-2029) & (US$ Million)
Figure 55. China Oral Contraceptive Drugs Sales Market Share by Type (2018-2029)
Figure 56. China Oral Contraceptive Drugs Revenue Market Share by Type (2018-2029)
Figure 57. China Oral Contraceptive Drugs Sales Market Share by Application (2018-2029)
Figure 58. China Oral Contraceptive Drugs Revenue Market Share by Application (2018-2029)
Figure 59. Asia Oral Contraceptive Drugs Sales Market Share by Type (2018-2029)
Figure 60. Asia Oral Contraceptive Drugs Revenue Market Share by Type (2018-2029)
Figure 61. Asia Oral Contraceptive Drugs Sales Market Share by Application (2018-2029)
Figure 62. Asia Oral Contraceptive Drugs Revenue Market Share by Application (2018-2029)
Figure 63. Asia Oral Contraceptive Drugs Revenue Share by Region (2018-2029)
Figure 64. Asia Oral Contraceptive Drugs Sales Share by Region (2018-2029)
Figure 65. Japan Oral Contraceptive Drugs Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Oral Contraceptive Drugs Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Oral Contraceptive Drugs Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Oral Contraceptive Drugs Revenue (2018-2029) & (US$ Million)
Figure 69. India Oral Contraceptive Drugs Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Oral Contraceptive Drugs Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Oral Contraceptive Drugs Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Oral Contraceptive Drugs Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Oral Contraceptive Drugs Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Oral Contraceptive Drugs Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Oral Contraceptive Drugs Sales Share by Country (2018-2029)
Figure 76. Brazil Oral Contraceptive Drugs Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Oral Contraceptive Drugs Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Oral Contraceptive Drugs Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Oral Contraceptive Drugs Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Oral Contraceptive Drugs Revenue (2018-2029) & (US$ Million)
Figure 81. Oral Contraceptive Drugs Value Chain
Figure 82. Oral Contraceptive Drugs Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed


More Publications